News for Healthier Living

How a CRISPR Sickle Cell Therapy Moved From Lab to Clinical Trial

A UCLA-led team has described how they advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell therapy that can be manufactured at the scale and quality required for a clinical trial.

November 4, 2026


November 5 2026

November 4 2026

November 3 2026

November 2 2026

November 1 2026

October 30 2026

October 29 2026

October 28 2026

October 27 2026

October 26 2026

October 25 2026

October 24 2026

October 23 2026